NATIXIS PARTNERS ACTED AS EXCLUSIVE FINANCIAL ADVISOR TO ANDERA ACTO IN ITS INVESTMENT IN EFOR ALONGSIDE THE FOUNDER MATHIEU ROGER, THE MANAGEMENT TEAM, AND RAISE INVEST, HISTORICAL PARTNER OF THE GROUP

After a decade in business, the EFOR group has firmly established itself as one of the European leaders in life sciences consultancy. With 2,000 employees spread across 19 agencies in 4 countries, and generating a turnover of €175 million in 2023, EFOR has been able to meet the constantly evolving needs of the pharmaceutical, biotechnology, and medtech sectors. Since its inception, EFOR has demonstrated continuous growth exceeding 20% per year in a resilient market, in full globalization and in search of trusted players to outsource strategic activities throughout the product life cycle, requiring increasingly sophisticated technical and scientific expertise. With this operation, EFOR reaffirms its ambition to become a global leader in its market within the next five years. To achieve this goal, the group aims to extend its international reach, particularly in Europe and the USA, to invest in the development of its offers and expertise, and to reach 5,000 employees by 2028.